Veeda CR Installs India's First Ever Clinical Pharmacology Unit For Renal Impaired Patients

VEEDA CR, India's fastest growing Clinical Research Organisation (CRO), today opened it's new Clinical Pharmacology Unit (CPU) at Muljibhai Patel Urological Hospital (MPUH), Nadiad, Gujarat.

Dinsha Patel & Nlllma Kshirsagar inaugurated the Unit at Muljibhai Patel Urological Hospital, Gujarat

VEEDA CR, India's fastest growing Clinical Research Organisation (CRO), today opened it's new Clinical Pharmacology Unit (CPU) at Muljibhai Patel Urological Hospital (MPUH), Nadiad, Gujarat. The unit was inaugurated by Mr. Dinsha J. Patel, Minister of State for Petroleum & Natural Gas & Dr. Nilima Kshirsagar (Director Professor, Infectious Diseases & Interdisciplinary Research, Maharashtra University of Health Sciences). Veeda will conduct Phase I /II clinical studies in Renal Impaired Patients, at the Unit.

Dr. Kiran Marthak, Director - Veeda CR said, "Conducting Phase I studies on renal impaired patients is highly important as many drugs are excreted by the body via the kidneys and a knowledge of the influence of kidney function on drug metabolism is essential to drug development. Veeda Clinical Research is very proud to become the first ever CRO to establish a specialized renal CPU in India. Veeda would also utilize this unit for carrying out Clinical Trials related to Urology like Ca Prostate and Ca Bladder which may necessitate admission in the ward which is in the hospital and immediately adjacent to the intensive care Unit The Unit has six fully monitored beds and all the supporting facilities necessary for the safe conduct of clinical trials in this special population. Working in this hospital gives us access to the full spectrum of patients with impaired kidney function from the mildest to the most severe"

Veeda CR has access to the experienced manpower of the hospital as well as the facilities available like Kidney Dialysis Machines, Pathology Laboratory, X-rays and CT scan.

Studies involving renal impaired patients are particularly important for newly discovered drugs for which the way in which the body handles the drug is not known.

About Veeda:
The Veeda CR service blends 20 years of phase I expertise in UK and Germany with the substantial benefits, both intellectual and economic, of the Indian sub Continent. With the acquisition of DICE, a highly specialised data management CRO in Brussels, Veeda CR is well placed to deliver cost effective, timely research solutions to the pharmaceutical and biotechnology industries worldwide.

Veeda CR is capable of handling ail types of phase I and BA/BE studies-from technically complex trials to the more routine PK studies. We have a dedicated clinical pathology, bioanalysis, biomarker and immunogenicity laboratory which is GLP accredited. We have access to populations of patients, both treated and treatment-naive, as well as diabetics, hypertensive and asthmatic patients and also have unrivalled access to subjects with various cancers, renal impairment and cardiovascular conditions.

About MPUH:

MPUH, which is about 40 kms from Ahmedabad, is a premier institution providing health services in Urology and Nephrology including kidney transplantation and post graduate education centre for DNB. It has developed an affiliation with the University of Arkansas Medical Centre for ongoing collaboration and exchange


Contact Details

Company Name: Veedacr
Issued By: Veeda
Website: Visit the website

by Veeda (few years ago!)

Latest Press Releases

The Mad Hatter Now Offer a Full Line of Hearth Products and Full Line of Grills

Diabetes Insulin Delivery Pens Market Research Report 2018

Dr Kapadia Provides Tips to Patients Interested in Hair Transplant Procedures

love vashikaran specialist

Solar Blanket Sales Market Report 2018

Spring Bottled Water Market Insights, Forecast to 2025

Biochemical Incubator Sales Market Report 2018

Quinine Sulphate Sales Market Report 2018

Automotive Chassisc System Market Insights, Forecast to 2025

2,6-Dicarboxypyridine market size in key regions like North America, Europe, Asia Pacific an..

Remove this press release ?

Due to extra work required to remove the press-releases we have started charging $1.99 for press release removal.

Your press release will be removed in 24 hours, once the payment has been received.

Search Press Release
e.g. Business, Computer, etc.